On Sunday Night CytoDyn Inc. (OTCMKTS:CYDY) quietly placed a link in their developing news section to a 2016 medical journal article that...
Our job at Insider Financial is to have our fingers on the pulse of what’s happening in the penny stock world for...
Last week’s negative FDA advisory committee vote may be the final nail in the coffin in the up-and-down registration path of Biogen...
CytoDyn Inc. (OTCMKTS:CYDY) on a conference call yesterday revealed that approximately 250 patients have been recruited in their CD12 severe to cri...
Relief Therapeutics and its shareholders have had a tough couple of days. This came as fear, uncertainty, and doubt (FUD) spread throughout...
The only reason to trade penny stocks is for the explosive moves they can make. If a penny stock doesn’t have triple-digit...
IPIX Stock is gearing up for a major move after receiving a Pre-IND response from the FDA on its planned clinical trial. This...
Revive Therapeutics remains one of the most undervalued companies trading on the OTC Markets. We first covered Revive in September when shares...
Humanigen is the Rodney Dangerfield of the Biotech world. The company just cannot get any respect. A big part is that many...
AVXL stock was a big winner for us here at Insider Financial back in 2015 when we caught the run from $1 to...